|Temporal transcriptional response to ethylene gas drives growth hormone cross-regulation in Arabidopsis|
KN Chang, S Zhong, MT Weirauch, G Hon, M Pelizzola, H Li, SC Huang, ...
Elife 2, e00675, 2013
|Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting|
J He, O Abdel-Wahab, MK Nahas, K Wang, RK Rampal, AM Intlekofer, ...
Blood 127 (24), 3004-3014, 2016
|DREM 2.0: Improved reconstruction of dynamic regulatory networks from time-series expression data|
MH Schulz, WE Devanny, A Gitter, S Zhong, J Ernst, Z Bar-Joseph
BMC Systems Biology 6 (1), 104, 2012
|Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA|
TA Clark, JH Chung, M Kennedy, JD Hughes, N Chennagiri, DS Lieber, ...
The Journal of Molecular Diagnostics 20 (5), 686-702, 2018
|Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors|
MN Nikiforova, AI Wald, MA Melan, S Roy, S Zhong, RL Hamilton, ...
Neuro-oncology 18 (3), 379-387, 2016
|DECOD: fast and accurate discriminative DNA motif finding|
P Huggins, S Zhong, I Shiff, R Beckerman, O Laptenko, C Prives, ...
Bioinformatics 27 (17), 2361-2367, 2011
|A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing|
C Beadling, AI Wald, A Warrick, TL Neff, S Zhong, YE Nikiforov, ...
The Journal of Molecular Diagnostics 18 (2), 165-175, 2016
|Molecular characterization of sporadic pediatric thyroid carcinoma with the DNA/RNA ThyroSeq v2 next-generation sequencing assay|
JL Picarsic, MA Buryk, J Ozolek, S Ranganathan, SE Monaco, JP Simons, ...
Pediatric and Developmental Pathology 19 (2), 115-122, 2016
|Biological interaction networks are conserved at the module level|
GE Zinman, S Zhong, Z Bar-Joseph
BMC systems biology 5 (1), 134, 2011
|THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer|
F Panebianco, LM Kelly, P Liu, S Zhong, S Dacic, X Wang, AD Singhi, ...
Proceedings of the National Academy of Sciences 114 (9), 2307-2312, 2017
|Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia|
FC Brown, P Cifani, E Drill, J He, E Still, S Zhong, S Balasubramanian, ...
British journal of haematology 176 (1), 86-91, 2017
|Predicting tissue specific transcription factor binding sites|
S Zhong, X He, Z Bar-Joseph
BMC Genomics 14 (1), 796, 2013
|102PAnalytic validation of a next generation sequencing assay to identify tumor mutational burden from blood (bTMB) to support investigation of an anti-PD-L1 agent …|
D Fabrizio, C Malboeuf, D Lieber, S Zhong, J He, E White, M Coyne, ...
Annals of Oncology 28 (suppl_5), 2017
|Kinase domain activation through gene rearrangement in multiple myeloma|
GJ Morgan, J He, R Tytarenko, P Patel, OW Stephens, S Zhong, ...
Leukemia 32 (11), 2435-2444, 2018
|Primary Undifferentiated Sarcoma of the Kidney Harboring a Novel Variant of CIC-DUX4 Gene Fusion|
S Mangray, GR Somers, J He, S Zhong, M Shago, DO Treaba, ...
The American Journal of Surgical Pathology 40 (9), 1298-1301, 2016
|Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling|
K Tarlock, S Zhong, Y He, R Ries, E Severson, M Bailey, S Morley, ...
Oncotarget 9 (41), 26417, 2018
|Clinicopathologic features of a series of primary renal CIC-rearranged sarcomas with comprehensive molecular analysis|
S Mangray, DR Kelly, S LeGuellec, E Fridman, S Aggarwal, M Shago, ...
The American journal of surgical pathology 42 (10), 1360-1369, 2018
|Analytic validation of a clinical circulating tumor DNA assay for patients with solid tumors|
PJ Stephens, T Clark, M Kennedy, J He, G Young, M Zhao, M Coyne, ...
Annals of Oncology 27 (suppl 6), 1159PD, 2016
|Primary Spinal Epidural CIC-DUX4 Undifferentiated Sarcoma in a Child|
JE Donahue, E Yakirevich, S Zhong, DO Treaba, NS Lakis, SM Ali, ...
Pediatric and Developmental Pathology 21 (4), 411-417, 2018
|Analytic validation and clinical feasibility of a next-generation sequencing assay to assess tumor mutational burden from blood (bTMB) as a biomarker for anti-PD-L1 response in …|
DS Lieber, E White, J Silterra, S Zhong, T Brennan, M Coyne, M Kennedy, ...
CANCER IMMUNOLOGY RESEARCH 6 (9), 2018